ROCKVILLE, Md. — The FDA today approved Gardasil (quadrivalent human papillomavirus [Types 6, 11, 16, 18] recombinant vaccine) for prevention of cervical cancer and for prevention of cervical, vulvar and vaginal pre-cancers caused by HPV types 16 and 18.
ATLANTA ? Gardasil (quadrivalent human papillomavirus [Types 6, 11, 16, 18]), the vaccine that is pending FDA approval for cervical cancer, is also 100% effective against HPV-related vaginal and vulvar lesions, researchers reported here.
Nongenital cutaneous warts--that is, common, plantar, filiform, and flat warts--are manifestations of the human papillomavirus (HPV). These warts are among the most common dermatologic complaints seen in primary care practices and are among the most common lesions treated by dermatologists.